{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:05:53Z","timestamp":1778774753073,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1791"],"award-info":[{"award-number":["2024NSFSC1791"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33657-5","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T23:54:29Z","timestamp":1766447669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nomogram based on CT and clinical features to predict R0 resection in patients with stage IIB\u2013IV epithelial ovarian cancer: a multi-center study"],"prefix":"10.1038","volume":"16","author":[{"given":"Xia","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-mei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-mei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-ping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-xiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-xin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"33657_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries, CA. Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"Cancer J. Clin."},{"key":"33657_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb, P. M. & Jordan, S. J. Global epidemiology of epithelial ovarian cancer. Nat. Rev. Clin. Oncol. 21, 389\u2013400. https:\/\/doi.org\/10.1038\/s41571-024-00881-3 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"33657_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.6004\/jnccn.2024.0052","volume":"22","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. NCCN guidelines\u00ae insights: ovarian Cancer\/Fallopian tube Cancer\/Primary peritoneal Cancer, version 3.2024: featured updates to the NCCN guidelines. J. Natl. Compr. Canc Netw. 22, 512\u2013519. https:\/\/doi.org\/10.6004\/jnccn.2024.0052 (2024).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"33657_CR4","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Du Bois","year":"2009","unstructured":"Du Bois, A. et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the arbeitsgemeinschaft gynaekologische onkologie studiengruppe ovarialkarzinom (AGO\u2010OVAR) and the groupe d\u2019investigateurs Nationaux pour les etudes des cancers de l\u2019ovaire (GINECO). Cancer 115, 1234\u20131244. https:\/\/doi.org\/10.1002\/cncr.24149 (2009).","journal-title":"Cancer"},{"key":"33657_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/cancers12030768","volume":"12","author":"B Delga","year":"2020","unstructured":"Delga, B. et al. 30 years of experience in the management of stage III and IV epithelial ovarian cancer: impact of surgical strategies on survival. Cancers 12, 768. https:\/\/doi.org\/10.3390\/cancers12030768 (2020).","journal-title":"Cancers"},{"key":"33657_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2478\/raon-2018-0030","volume":"52","author":"B Kobal","year":"2018","unstructured":"Kobal, B. et al. Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals. Radiol. Oncol. 52, 307\u2013319. https:\/\/doi.org\/10.2478\/raon-2018-0030 (2018).","journal-title":"Radiol. Oncol."},{"key":"33657_CR7","doi-asserted-by":"publisher","first-page":"e0187245","DOI":"10.1371\/journal.pone.0187245","volume":"12","author":"M Chesnais","year":"2017","unstructured":"Chesnais, M. et al. A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer. PLOS ONE. 12, e0187245. https:\/\/doi.org\/10.1371\/journal.pone.0187245 (2017).","journal-title":"PLOS ONE"},{"key":"33657_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1245\/s10434-019-07626-y","volume":"27","author":"MY Zaidi","year":"2020","unstructured":"Zaidi, M. Y. et al. Preoperative risk score for predicting incomplete cytoreduction: A 12-Institution study from the US HIPEC Collaborative, ann. Surg. Oncol. 27, 156\u2013164. https:\/\/doi.org\/10.1245\/s10434-019-07626-y (2020).","journal-title":"Surg. Oncol."},{"key":"33657_CR9","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1200\/JCO-24-02589","volume":"43","author":"S Gaillard","year":"2025","unstructured":"Gaillard, S. et al. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: ASCO guideline update. J. Clin. Oncol. 43, 868\u2013891. https:\/\/doi.org\/10.1200\/JCO-24-02589 (2025).","journal-title":"J. Clin. Oncol."},{"key":"33657_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","volume":"145","author":"RS Suidan","year":"2017","unstructured":"Suidan, R. S. et al. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecol. Oncol. 145, 27\u201331. https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.020 (2017).","journal-title":"Gynecol. Oncol."},{"key":"33657_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/IJWH.S198355","volume":"11","author":"A Llueca","year":"2019","unstructured":"Llueca, A. et al. A radiologic-laparoscopic model to predict suboptimal (or complete and optimal) debulking surgery in advanced ovarian cancer: a pilot study. Int. J. Womens Health Volume. 11, 333\u2013342. https:\/\/doi.org\/10.2147\/IJWH.S198355 (2019).","journal-title":"Int. J. Womens Health Volume"},{"key":"33657_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/0284185116658683","volume":"58","author":"HM Son","year":"2017","unstructured":"Son, H. M. et al. Preoperative prediction of suboptimal resection in advanced ovarian cancer based on clinical and CT parameters. Acta Radiol. 58, 498\u2013504. https:\/\/doi.org\/10.1177\/0284185116658683 (2017).","journal-title":"Acta Radiol."},{"key":"33657_CR13","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.3802\/jgo.2018.29.e65","volume":"29","author":"Z Feng","year":"2018","unstructured":"Feng, Z. et al. A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study. J. Gynecol. Oncol. 29, e65. https:\/\/doi.org\/10.3802\/jgo.2018.29.e65 (2018).","journal-title":"J. Gynecol. Oncol."},{"key":"33657_CR14","unstructured":"Avesani, G. & Torino radiological assessment of peritoneal cancer index on preoperative CT in ovarian cancer is related to surgical outcome and survival. Radiol. Med.."},{"key":"33657_CR15","doi-asserted-by":"publisher","unstructured":"Gu, B., Xia, L., Ge, H. & Liu, S. Preoperative PET\/CT score can predict complete resection in advanced epithelial ovarian cancer: a prospective study. Quant. Imaging Med. Surg. 10,  743\u2013753  https:\/\/doi.org\/10.21037\/qims.2020.02.19 (2020).","DOI":"10.21037\/qims.2020.02.19"},{"key":"33657_CR16","doi-asserted-by":"crossref","unstructured":"Asp, M. The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC). Arch. Gynecol. Obstet. (2022).","DOI":"10.1007\/s00404-022-06466-8"},{"key":"33657_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7800-2-3","volume":"2","author":"RL Harmon","year":"2005","unstructured":"Harmon, R. L. & Sugarbaker, P. H. Prognostic indicators in peritoneal carcinomatosis from Gastrointestinal cancer. Int. Semin Surg. Oncol. 2, 3. https:\/\/doi.org\/10.1186\/1477-7800-2-3 (2005).","journal-title":"Int. Semin Surg. Oncol."},{"key":"33657_CR18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00404-022-06527-y","volume":"306","author":"FL Rawert","year":"2022","unstructured":"Rawert, F. L. et al. The importance of the peritoneal cancer index (PCI) to predict surgical outcome after neoadjuvant chemotherapy in advanced ovarian cancer. Arch. Gynecol. Obstet. 306, 1665\u20131672. https:\/\/doi.org\/10.1007\/s00404-022-06527-y (2022).","journal-title":"Arch. Gynecol. Obstet."},{"key":"33657_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/cancers15020500","volume":"15","author":"MC Di Donna","year":"2023","unstructured":"Di Donna, M. C. et al. Concordance of Radiological, laparoscopic and laparotomic scoring to predict complete cytoreduction in women with advanced ovarian cancer. Cancers 15, 500. https:\/\/doi.org\/10.3390\/cancers15020500 (2023).","journal-title":"Cancers"},{"key":"33657_CR20","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.1007\/s13277-016-5335-0","volume":"37","author":"Y Shen","year":"2016","unstructured":"Shen, Y. & Li, L. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer. Tumor Biol. 37, 14765\u201314772. https:\/\/doi.org\/10.1007\/s13277-016-5335-0 (2016).","journal-title":"Tumor Biol."},{"key":"33657_CR21","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.7150\/jca.25184","volume":"9","author":"CH Luo","year":"2018","unstructured":"Luo, C. H. et al. HE4 and eIF3a expression correlates with surgical outcome and overall survival in ovarian cancer patients with secondary cytoreduction. J. Cancer. 9, 2472\u20132479. https:\/\/doi.org\/10.7150\/jca.25184 (2018).","journal-title":"J. Cancer"},{"key":"33657_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ygyno.2012.11.040","volume":"128","author":"R Angioli","year":"2013","unstructured":"Angioli, R. et al. Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? Gynecol. Oncol. 128, 579\u2013583. https:\/\/doi.org\/10.1016\/j.ygyno.2012.11.040 (2013).","journal-title":"Gynecol. Oncol."},{"key":"33657_CR23","doi-asserted-by":"publisher","first-page":"26102","DOI":"10.1038\/s41598-024-76052-2","volume":"14","author":"W Tong","year":"2024","unstructured":"Tong, W. et al. Inflammatory factors are associated with prognosis of non-small cell lung cancer patients receiving immunotherapy: a meta-analysis. Sci. Rep. 14, 26102. https:\/\/doi.org\/10.1038\/s41598-024-76052-2 (2024).","journal-title":"Sci. Rep."},{"key":"33657_CR24","doi-asserted-by":"publisher","first-page":"20489","DOI":"10.1038\/s41598-024-68150-y","volume":"14","author":"X Shen","year":"2024","unstructured":"Shen, X. et al. Evaluation of peripheral blood inflammation indexes as prognostic markers for colorectal cancer metastasis. Sci. Rep. 14, 20489. https:\/\/doi.org\/10.1038\/s41598-024-68150-y (2024).","journal-title":"Sci. Rep."},{"key":"33657_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","volume":"36","author":"TH N\u00f8st","year":"2021","unstructured":"N\u00f8st, T. H. et al. Systemic inflammation markers and cancer incidence in the UK biobank. Eur. J. Epidemiol. 36, 841\u2013848. https:\/\/doi.org\/10.1007\/s10654-021-00752-6 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"33657_CR26","doi-asserted-by":"crossref","unstructured":"Vergote, I., Amant, F. & Ehlen, T. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N. Engl. J. Med. (2010).","DOI":"10.1056\/NEJMoa0908806"},{"key":"33657_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ygyno.2014.07.002","volume":"134","author":"RS Suidan","year":"2014","unstructured":"Suidan, R. S. et al. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecol. Oncol. 134, 455\u2013461. https:\/\/doi.org\/10.1016\/j.ygyno.2014.07.002 (2014).","journal-title":"Gynecol. Oncol."},{"key":"33657_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ygyno.2012.11.023","volume":"128","author":"EI Braicu","year":"2013","unstructured":"Braicu, E. I. et al. Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients. Gynecol. Oncol. 128, 245\u2013251. https:\/\/doi.org\/10.1016\/j.ygyno.2012.11.023 (2013).","journal-title":"Gynecol. Oncol."},{"key":"33657_CR29","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.3390\/diagnostics13132268","volume":"13","author":"AR Kov\u00e1cs","year":"2023","unstructured":"Kov\u00e1cs, A. R. et al. Prognostic significance of preoperative NLR, MLR, and PLR values in predicting the outcome of primary cytoreductive surgery in serous epithelial ovarian cancer. Diagnostics 13, 2268. https:\/\/doi.org\/10.3390\/diagnostics13132268 (2023).","journal-title":"Diagnostics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33657-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33657-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33657-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:32:22Z","timestamp":1769509942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33657-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33657"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33657-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Medical Ethics Committees of the Affiliated Hospital of North Sichuan Medical College (Institution1, No. 2024ER720-1), the Second School of Clinical Medicine, North Sichuan Medical College (Institution 2, No. 2024\u2009\u2212\u2009176), and the Zigong First People\u2019s Hospital (Institution 3, No. 2024-049). The study was conducted in accordance with the Declaration of Helsinki (2024 version). Due to the retrospective nature of the study, the institutional review boards of the Affiliated Hospital of North Sichuan Medical College, the Second School of Clinical Medicine, North Sichuan Medical College, and the Zigong First People\u2019s Hospital waived the need to obtain informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"3623"}}